Barnes Ryan H, Paterno Anthony V, Lin Feng-Chang, Zhang Jingru, Berkoff David, Creighton R Alexander
Department of Orthopaedics, University of North Carolina Hospitals, Chapel Hill, North Carolina, USA.
Department of Biostatistics, University of North Carolina, Chapel Hill, North Carolina, USA.
Orthop J Sports Med. 2022 Jun 14;10(6):23259671221104505. doi: 10.1177/23259671221104505. eCollection 2022 Jun.
Postoperative stiffness is a known complication after rotator cuff repair (RCR). Glenohumeral hydrodistension (GH) has been a treatment modality for shoulder pathology but has not been used to treat postoperative stiffness after RCR.
PURPOSE/HYPOTHESIS: The purpose of this study was to identify the risk factors for postoperative stiffness after RCR and review outcomes after treatment with GH. Our hypotheses were that stiffness would be associated with diabetes and hyperlipidemia and correlated with the tendons involved and that patients with stiffness who underwent GH would have significant improvement in range of motion (ROM).
Case series; Level of evidence, 4.
Included were 388 shoulders of patients who underwent primary RCR by a single surgeon between 2015 and 2019. Shoulders with revision RCRs were excluded. Patient characteristics, medical comorbidities, and perioperative details were collected. A total of 40 shoulders with postoperative stiffness (10.3%) received GH injectate of a 21-mL mixture (15 mL of sterile water, 5 mL of 0.5% ropivacaine, and 1 mL of triamcinolone [10 mg/mL]). The primary outcome measure was ROM in forward flexion, internal rotation, external rotation, and abduction. Statistical tests were performed using analysis of variance.
Patients with diabetes had significantly decreased internal rotation at final follow-up after RCR as compared with patients without diabetes. GH to treat stiffness was performed most commonly between 1 and 4 months after RCR (60%), and patients who received GH saw statistically significant improvements in forward flexion, external rotation, and abduction after the procedure. Patients with hyperlipidemia had the most benefit after GH. Among those undergoing concomitant procedures, significantly more patients who had open subpectoral biceps tenodesis underwent GH. Patients who underwent subscapularis repair or concomitant subacromial decompression had significant improvement in ROM after GH. Only 1 patient who received GH underwent secondary surgery for resistant postoperative stiffness.
Patients with diabetes had increased stiffness. Patients with a history of hyperlipidemia or concomitant open subpectoral biceps tenodesis were more likely to undergo GH for postoperative stiffness. Patients who underwent subscapularis repair demonstrated the most improvement in ROM after GH. After primary RCR, GH can increase ROM and is a useful adjunct for patients with stiffness to limit secondary surgery.
术后僵硬是肩袖修复术(RCR)后已知的并发症。盂肱关节液压扩张术(GH)一直是治疗肩部疾病的一种方法,但尚未用于治疗RCR术后的僵硬。
目的/假设:本研究的目的是确定RCR术后僵硬的危险因素,并回顾GH治疗后的结果。我们的假设是,僵硬与糖尿病和高脂血症有关,与受累肌腱相关,并且接受GH治疗的僵硬患者的活动范围(ROM)将有显著改善。
病例系列;证据等级,4级。
纳入2015年至2019年间由单一外科医生进行初次RCR的患者的388个肩部。翻修RCR的肩部被排除。收集患者特征、内科合并症和围手术期细节。共有40个术后僵硬的肩部(10.3%)接受了21毫升混合液(15毫升无菌水、5毫升0.5%罗哌卡因和1毫升曲安奈德[10毫克/毫升])的GH注射。主要结局指标是前屈、内旋、外旋和外展的ROM。使用方差分析进行统计检验。
与无糖尿病患者相比,糖尿病患者在RCR最终随访时内旋显著降低。治疗僵硬的GH最常在RCR后1至4个月进行(60%),接受GH治疗的患者术后前屈、外旋和外展有统计学意义的改善。高脂血症患者在接受GH治疗后受益最大。在接受同期手术的患者中,接受开放性胸小肌下肱二头肌固定术的患者接受GH治疗的明显更多。接受肩胛下肌修复或同期肩峰下减压的患者在接受GH治疗后ROM有显著改善。接受GH治疗的患者中只有1例因术后僵硬难治而接受了二次手术。
糖尿病患者僵硬增加。有高脂血症病史或同期开放性胸小肌下肱二头肌固定术的患者更有可能因术后僵硬而接受GH治疗。接受肩胛下肌修复的患者在接受GH治疗后ROM改善最为明显。初次RCR后,GH可增加ROM,是僵硬患者限制二次手术的有用辅助手段。